Beyond Biotech podcast 35: Rare Disease Day
As February 28 is Rare Disease Day, we have three guests on the podcast today…
February 24, 2023 - 3 minutes
Replay Bio
Syena created to deliver first-in-class TCR-NK cell therapy
Replay, a genome writing company reprogramming biology by writing and delivering big DNA, and The…
February 14, 2023 - 4 minutes
Replay targets genetic brain disorders with new gene therapy company, Kaleibe
Replay, a genome writing company, today announced the launch of Kaleibe, an HSV gene therapy…
December 14, 2022 - 4 minutes
Replay receives $1.5M grant for hypoimmunogenic technology platform
Genome writing company Replay has received a $1.56 million grant from the Bill & Melinda…
November 28, 2022 - 3 minutes
New Replay HSV gene therapy company Telaria to focus on skin diseases
Replay has announced the launch of Telaria, a herpes simplex virus (HSV) gene therapy company…
November 21, 2022 - 3 minutes
Replay Bio launches HSV gene therapy company to target retinal eye disease
Replay Bio has announced the launch of Eudora, an HSV (herpes simplex virus) gene therapy…
October 31, 2022 - 4 minutes
